16.77
Overview
News
Price History
Option Chain
Financials
Why SLP Down?
Discussions
Forecast
Stock Split
Dividend History
Simulations Plus Inc stock is traded at $16.77, with a volume of 161.36K.
It is down -5.41% in the last 24 hours and up +12.47% over the past month.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
See More
Previous Close:
$17.73
Open:
$17.61
24h Volume:
161.36K
Relative Volume:
0.51
Market Cap:
$338.85M
Revenue:
$80.54M
Net Income/Loss:
$-62.79M
P/E Ratio:
-5.3693
EPS:
-3.1233
Net Cash Flow:
$20.76M
1W Performance:
+9.75%
1M Performance:
+12.47%
6M Performance:
-14.13%
1Y Performance:
-36.41%
Simulations Plus Inc Stock (SLP) Company Profile
Name
Simulations Plus Inc
Sector
Industry
Phone
661-723-7723
Address
800 PARK OFFICES DRIVE, SUITE 401, RESEARCH TRIANGLE PARK, CA
Compare SLP vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SLP
Simulations Plus Inc
|
16.77 | 358.24M | 80.54M | -62.79M | 20.76M | -3.1233 |
|
VEEV
Veeva Systems Inc
|
182.94 | 30.79B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
59.34 | 11.63B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
49.62 | 9.48B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
88.34 | 7.58B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
HNGE
Hinge Health Inc
|
58.48 | 4.71B | 646.34M | -512.40M | 202.76M | -6.6871 |
Simulations Plus Inc Stock (SLP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-25 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-30-25 | Initiated | TD Cowen | Hold |
| Jul-15-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-15-24 | Initiated | Stephens | Overweight |
| Jul-29-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-16-24 | Initiated | JMP Securities | Mkt Perform |
| Jun-28-24 | Initiated | William Blair | Outperform |
| May-09-23 | Initiated | BTIG Research | Buy |
| Oct-26-21 | Upgrade | Craig Hallum | Hold → Buy |
| Jan-12-21 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-16-20 | Initiated | Raymond James | Outperform |
| Sep-08-20 | Initiated | Oppenheimer | Outperform |
| Jan-06-20 | Initiated | Craig Hallum | Buy |
View All
Simulations Plus Inc Stock (SLP) Latest News
Insider Sell Alert: Walter Woltosz Sells 15,000 Shares of Simula - GuruFocus
SLP Shareholder Alert: Robbins LLP Reminds Simulation Plus, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders - GlobeNewswire Inc.
Simulations Plus (SLP) major holders sell 15,000 shares under 10b5-1 plan - Stock Titan
SLP Shareholder Alert: Robbins LLP Reminds Simulation Plus, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders - PR Newswire
Simulations Plus, Inc. (SLP) Securities Fraud Investigation: Johnson Fistel Investigates Investor Losses Following Revenue Outlook Revision, Impairment Charge, and Auditor Dispute - Business Wire
SLP (NASDAQ: SLP) Rule 144 notice reports 15,000-share resale - Stock Titan
Robbins LLP is Investigating Allegations that the Officers and Directors of Simulations Plus, Inc. (SLP) Violated Securities Laws and Breached Fiduciary Duties to Shareholders - The Joplin Globe
SLP Technical Analysis & Stock Price Forecast - Intellectia AI
Law firm probes Simulations Plus over potential securities law violations after sharp stock drops. - Pluang
Simulations Plus, Inc. Shareholders Are Encouraged to Reach - GlobeNewswire
Is It Too Late To Consider Buying Simulations Plus, Inc. (NASDAQ:SLP)? - Yahoo Finance
Regulatory confidence declines without transparent modeling, Simulations Plus warns - Traders Union
SLP Stock Price, Quote & Chart | SIMULATIONS PLUS INC (NASDAQ:SLP) - ChartMill
Price-Driven Insight from (SLP) for Rule-Based Strategy - Stock Traders Daily
Simulations Plus Inc. (SLP) Rises 1.72% – Testing Key Resistance ZoneUpthrust Pattern - Newser
Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference - Business Wire
(SLP) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Simulations Plus president sells $16,530 in company stock By Investing.com - Investing.com Australia
Simulations Plus president sells $16,530 in company stock - Investing.com UK
Simulations Plus (SLP) executive exercises options and sells 1,000 shares under 10b5-1 plan - Stock Titan
TradingKey - TradingKey
[144] Simulations Plus, Inc. SEC Filing - Stock Titan
Nicholas Company Inc. Buys 78,854 Shares of Simulations Plus, Inc. $SLP - MarketBeat
NVIDIA Pushes AI Into Drug Development With Simulations Plus Collaboration - Yahoo Finance
Simulations Plus unveils method for QST model integration with microphysiological data in liver risk analysis - Traders Union
Simulations Plus collaborates with NVIDIA during AI drug modeling push - MSN
Simulations Plus, Inc. (SLP): Investor Outlook With A 47% Potential Upside - DirectorsTalk Interviews
Simulations Plus (SLP) Partners with NVIDIA for Advanced Drug De - GuruFocus
Simulations Plus teams with NVIDIA on drug modeling - Engineering.com
Simulations Plus (NASDAQ:SLP) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Simulations Plus Collaborates With Nvidia During AI Drug Modeling Push - Dailyhunt
Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows - HPCwire
Simulations Plus partners with Nvidia on AI drug development By Investing.com - Investing.com India
Simulations Plus partners with Nvidia on AI drug development - Investing.com
Simulations Plus stock surges 28% on NVIDIA collaboration - Investing.com
Simulations Plus And NVIDIA Collaborate To Scale GPU-Accelerated, AI-Assisted Modeling Workflows - marketscreener.com
Insider Sell Alert: DiBella John Anthony II Sells Shares of Simu - GuruFocus
[Form 4] Simulations Plus, Inc. Insider Trading Activity - Stock Titan
Simulations Plus (SLP) insiders sell 15,000 shares in planned trade - Stock Titan
Do options traders know something about Simulations Plus stock we don't? - MSN
(SLP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Do Options Traders Know Something About Simulations Plus Stock We Don't? - TradingView
Simulations Plus (SLP) director receives 2,117-share equity grant as compensation - Stock Titan
Director Sharlene Evans receives 2,117 SLP shares in equity grant - Stock Titan
Director at Simulations Plus (SLP) receives 2,117-share stock grant - Stock Titan
Simulations Plus (SLP) director awarded 2,117 shares as equity compensation - Stock Titan
Simulations Plus Inc Stock (SLP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):